We provide you with 20 years of free, institutional-grade data for DAWN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of DAWN. Explore the full financial landscape of DAWN stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-05 | 1845337 | DAWN | 10-Q | Url |
| 2025-05-06 | 1845337 | DAWN | 10-Q | Url |
| 2025-02-25 | 1845337 | DAWN | 10-K | Url |
| 2024-10-30 | 1845337 | DAWN | 10-Q | Url |
| 2024-08-02 | 1845337 | DAWN | 10-Q | Url |
| 2024-05-06 | 1845337 | DAWN | 10-Q | Url |
| 2024-02-26 | 1845337 | DAWN | 10-K | Url |
| 2023-11-06 | 1845337 | DAWN | 10-Q | Url |
| 2023-08-07 | 1845337 | DAWN | 10-Q | Url |
| 2023-05-01 | 1845337 | DAWN | 10-Q | Url |
| 2023-03-06 | 1845337 | DAWN | 10-K | Url |
| 2022-11-07 | 1845337 | DAWN | 10-Q | Url |
| 2022-08-04 | 1845337 | DAWN | 10-Q | Url |
| 2022-05-12 | 1845337 | DAWN | 10-Q | Url |
| 2022-03-07 | 1845337 | DAWN | 10-K | Url |
| 2021-11-08 | 1845337 | DAWN | 10-Q | Url |
| 2021-08-10 | 1845337 | DAWN | 10-Q | Url |
| 2021-05-04 | 1845337 | DAWN | S-1 | Url |
Day One Biopharmaceuticals Inc(NASDAQ:DAWN) 
We are a unique company created to find and develop new therapies that meet the critical needs of people of all ages living with cancer – starting from the biology of childhood cancer. Our distinctive approach, together with our trusted network of pediatric oncology investigators, gives us an unpara...
Website: https://dayonebio.com/
Founded: 2018
IPO Price: $16 (May 27, 2021)
CEO: Jeremy Bender
Sector:
Industry:
Share this website to your friends
The information provided in this report about DAWN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.